ADARx bags USD 75 Million to advance its RNA tech pipeline ADARx Pharmaceuticals, a biotechnology company d...
Roche’s Genentech taps Adaptimmune for T-Cell Therapy Collaboration for USD 3 Billion A collaboration value...
Pfizer’s RSV Vaccine enters in the late-stage of clinical trials As the battle to get an effective Re...
FDA awards Breakthrough Device Designation to Impella ECP On August 18, 2021, Abiomed received breakthrough device designation from the United States Food and Drug Administration (FDA) fo...
FDA's Green Flag to Ascendis's Once-Weekly SKYTROFA for Treatment of Pediatric Growth Hormone DeficiencyFor the treatment of growth failure due to deficiency of growth hormones, the USFDA appr...
Shape Therapeutics inks gene therapy deal with Roche worth up to USD 3 BillionSeattle biotech firm Shape Therapeutics has signed a deal potentially exceeding USD 3 billion with pharma giant Ro...
AstraZeneca's Newly Occupied Alexion Hits Rock Bottom After Ultomiris (Ravulizumab) Fails to Show Efficacy in Patients with Amyotrophic Lateral SclerosisAstraZeneca's 39 billion USD complete a...
Boston Scientific starts recruitment for randomized controlled trials for the EkoSonic™ Endovascular SystemOn August 04, 2021, Boston Scientific Corporation started the enrolment in the...
FDA’s Green Flag to Keytruda and Lenvima combination by Merck and Eisai for Advanced renal cell carcinoma (RCC)The FDA approved the combination of Keytruda and Lenvima produced by Merck and Ei...
According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....
Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....
Prostate Cancer is the second most common malignancy in men worldwide, after lung cancer. Most Prost.....
Cancer is a leading cause of global death, accounting for nearly 10 million deaths in 2...
The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...
Neurological disorders are one of the major causes of death and disability across the g...
As per the American Autoimmune Related Diseases Association (AARDA), nearly 50 million ...
UNITY Biotechnology declares positive data from phase 1 clinical trial of UBX1325 in Ad...
